ALK and T-cell non-Hodgkin lymphoma: Our data suggest that STING may represent a novel marker for NHLs of T- or NK-cell lineage which can be used as a diagnostic marker for certain T-cell lymphomas with “null” cell immunophenotype (i.e., “null” cases of ALK-ALCL).